BRIEF published on 07/15/2026 at 17:50, 5 days 9 hours ago Medincell Aligns Debt Maturity with Revenue Growth Expectations Revenue Growth Non-dilutive Financing Olanzapine LAI UZEDY® Debt Maturity Alignment
PRESS RELEASE published on 07/15/2026 at 17:45, 5 days 9 hours ago Inside Information / Other news releases Medincell aligns debt maturity with expected revenue growth trajectory by securing €28 million non-dilutive new bank loans and early repayment of €20 million EIB credit facility tranche Revenue Growth Debt Maturity Medincell Bank Loans EIB Credit Facility
BRIEF published on 06/16/2026 at 21:21, 1 month 4 days ago Medincell: Key Results and Initiatives for 2025-2026 Innovation Treasury R&D Royalties Medincell
BRIEF published on 05/21/2026 at 19:29, 1 month 30 days ago EMA Accepts Teva's Application for Long-Acting Schizophrenia Treatment Schizophrenia Treatment Teva Pharmaceuticals EMA Approval Olanzapine Injectable Long-acting Formulation
PRESS RELEASE published on 05/21/2026 at 19:24, 1 month 30 days ago Inside Information / Other news releases European Medicines Agency accepts Teva's Marketing Authorization Application for Olanzapine Long-Acting Injectable to treat schizophrenia in adults. Teva and Medincell announce EMA acceptance for innovative treatment option Schizophrenia Medincell Olanzapine Teva EMA
BRIEF published on 04/29/2026 at 13:44, 2 months 21 days ago Impressive sales growth for UZEDY® in Q1 2026 Schizophrenia Medincell Teva Pharmaceuticals UZEDY® Q1 2026 Sales
BRIEF published on 04/29/2026 at 13:44, 2 months 21 days ago UZEDY® Q1 2026 Sales Surge by 62% FDA Approvals Olanzapine LAI UZEDY® Sales Teva Partnership Medincell Growth
PRESS RELEASE published on 04/29/2026 at 13:39, 2 months 21 days ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
BRIEF published on 04/20/2026 at 11:18, 3 months ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/02/2026 at 19:05, 3 months 18 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
Published on 07/21/2026 at 01:00, 2 hours 28 minutes ago Namibia Critical Metals Launches Next Phase of Lofdal Definitive Feasibility Study Including Further Value Addition in Namibia
Published on 07/20/2026 at 22:30, 4 hours 58 minutes ago Fermi Announces Second Quarter 2026 Earnings Release and Call Date
Published on 07/20/2026 at 22:30, 4 hours 58 minutes ago Grid Metals Enters Into Joint Venture Agreement with Avenir Minerals for Falcon West Cesium Project
Published on 07/20/2026 at 22:15, 5 hours 13 minutes ago Gamma Announces $2.1 Million LIFE Private Placement Offering
Published on 07/20/2026 at 20:25, 7 hours 3 minutes ago Taranis Offers a Fully Domestic Source of Critical Minerals as it Initiates New Tests for Even More Critical Mineral Elements, and Acquires New Mineral Tenures at Thor Project
Published on 07/20/2026 at 21:10, 6 hours 18 minutes ago STEICO SE: Half-Year Report 2026 – catch-up effects in the second quarter, along with cost pressures
Published on 07/20/2026 at 19:16, 8 hours 12 minutes ago EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
Published on 07/20/2026 at 19:00, 8 hours 28 minutes ago Notification of Stabilization Measures and Their Completion in accordance with Art. 5 (4) lit. b), (5), (6) of Regulation (EU) 596/2014 of the European Parliament and of the Council on Market Abuse
Published on 07/20/2026 at 18:19, 9 hours 9 minutes ago EQS-Adhoc: Hamburger Hafen und Logistik AG: HHLA lowers expectations for the 2026 financial year
Published on 07/20/2026 at 18:20, 9 hours 8 minutes ago Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 9 hours 23 minutes ago Reporting on share buyback transactions carried out between July 8 and July 9, 2026
Published on 07/20/2026 at 17:40, 9 hours 48 minutes ago Mersen selected to supply Ford and Leapmotor with fuses for electric vehicles
Published on 07/20/2026 at 14:25, 13 hours 2 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from July 13 to July 17 2026
